المؤلفون: Carlos Guijarro, Farid Zand, Mohamed solyman Kabil, Sven Trelle, Birgitte Tholin, Belén Comeche, Johan Alexander Azañero Haro, Gonzalo Sierra Torres, Quarraisha Abdool Karim, Kari Tikkinen, Jean-michel Molina, Atousa Hakamifard, George M Varghese, Oscar Josue Ponce Ponte, Mazin Barry, Pilar Vizcarra, Niccolo Riccardi, Natalia Pérez-Macias, Aynaa AlSharidi, Nelson Lee, Alexandra Binnie, Firouzé BANI-SADR, Beatriz Díaz-Pollán, Aldo Pietro Maggioni, Ilkka Kalliala, Florian Desgranges, Anders Benjamin Kildal, Katerina Nezvalova-Henriksen, Corinne Merle, Andrés Martín Alcántara, Benjamin Gaborit, Daniel Lozano Martín, Antonio Ramos-Martinez, Miguel Villegas-Chiroque, Fredy Orlando Guevara Pulido, Ana Fernández-Cruz, Cormac McCarthy, Thesla Palanee-Phillips, Annalisa Marinosci, Abdullah Assiri, Florent Wallet, Juan Pablo Balbuena, Avik Ray, Francesc Puchades, Rajarao Mesipogu, Marjatta Sinisalo, Jonathan Sterne, Antonio Portolés, Heike Cappel-Porter, Jussi Mustonen, Jeremy Nel, BRUNO MOURVILLIER, María Consuelo Miranda Montoya, Chiara Fanciulli, L Marjukka Myllärniemi, Edinson Dante Meregildo Rodriguez, Alexy Inciarte, Mohamed Hassany, François Danion, Elena Muñez Rubio, Jean-Pierre QUENOT, Esperanza Merino de Lucas, Sheela Godbole, Luis Guillermo Barreto Rocchetti, Katerina Spasovska, William Connors, Kiana Shirani, Umang Agrawal, Srinivas Murthy, Bjorn Blomberg, Vasee Moorthy, Amith Balachandran, Antonio De Pablo Esteban, Mahnaz Amini, Dag Arne Lihaug Hoff, Zeinab Siami, Guillaume Martin-Blondel, Heng Gee Lee, Thrilok Chander Bingi, Vijay Krishnan, ANA BELEN RIVAS PATERNA, Eric D'Ortenzio, Samy Zaky, Carlos Arturo Alvarez-Moreno, Alonso Soto, VIKAS MARWAH, Marco Tulio Medina, Zaira R. Palacios-Baena, Jean-Sébastien Hulot, Miguel Angel Hueda Zavaleta, Felipe García, Francisco Fanjul

المساهمون: Hospices Civils de Lyon (HCL), INSERM UMR-S 606, Hôpital Lariboisière, Assistance Publique-Hôpitaux de Paris, PRES Sorbonne Paris-Cité, and Université Paris Denis Diderot, Université Paris Diderot - Paris 7 (UPD7), Michel-Avella, Amandine, Pan, H., Peto, R., Henao-Restrepo, A. -M., Preziosi, M. -P., Sathiyamoorthy, V., Karim, Q. A., Alejandria, M. M., Garcia, C. H., Kieny, M. -P., Malekzadeh, R., Murthy, S., Srinath Reddy, K., Periago, M. R., Hanna, P. A., Ader, F., Al-Bader, A. M., Alhasawi, A., Allum, E., Alotaibi, A., Alvarez-Moreno, C. A., Appadoo, S., Asiri, A., Aukrust, P., Barratt-Due, A., Bellani, S., Branca, M., Cappel-Porter, H. B. C., Cerrato, N., Chow, T. S., Como, N., Eustace, J., Garcia, P. J., Godbole, S., Gotuzzo, E., Griskevicius, L., Hamra, R., Hassan, M., Hassany, M., Hutton, D., Irmansyah, I., Jancoriene, L., Kirwan, J., Kumar, S., Lennon, P., Lopardo, G., Lydon, P., Magrini, N., Maguire, T., Manevska, S., Manuel, O., Mcginty, S., Medina, M. T., Mesa Rubio, M. L., Miranda-Montoya, M. C., Nel, J., Nunes, E. P., Perola, M., Portoles, A., Rasmin, M. R., Raza, A., Rees, H., Reges, P. P. S., Rogers, C. A., Salami, K., Salvadori, M. I., Sinani, N., Sterne, J. A. C., Stevanovikj, M., Tacconelli, E., Tikkinen, K. A. O., Trelle, S., Zaid, H., Rottingen, J. -A., Swaminathan S., &, Luzzati, R, Di Bella, S, Doctoral Programme in Population Health, Doctoral Programme in Biomedicine, HUS Abdominal Center, Department of Surgery, Urologian yksikkö, South Carelia Social and Health care District Eksote, HUS Heart and Lung Center, Department of Medicine, Clinicum, Department of Obstetrics and Gynecology, HUS Gynecology and Obstetrics, UCL - SSS/IREC/LTAP - Louvain Centre for Toxicology and Applied Pharmacology, UCL - (SLuc) Service de médecine interne générale

المصدر: New England Journal of Medicine
New England Journal of Medicine, Massachusetts Medical Society, 2021, 384 (6), pp.497-511. ⟨10.1056/NEJMoa2023184⟩
Pan, Hongchao; Peto, Richard; Henao-Restrepo, Ana-Maria; Preziosi, Marie-Pierre; Sathiyamoorthy, Vasee; Abdool Karim, Quarraisha; Alejandria, Marissa M; Hernández García, César; Kieny, Marie-Paule; Malekzadeh, Reza; Murthy, Srinivas; Reddy, K Srinath; Roses Periago, Mirta; Abi Hanna, Pierre; Ader, Florence; Al-Bader, Abdullah M; Alhasawi, Almonther; Allum, Emma; Alotaibi, Athari; Alvarez-Moreno, Carlos A; ... (2021). Repurposed Antiviral Drugs for Covid-19-Interim WHO Solidarity Trial Results. New England journal of medicine NEJM, 384(6), pp. 497-511. Massachusetts Medical Society MMS 10.1056/NEJMoa2023184 <http://dx.doi.org/10.1056/NEJMoa2023184Test>
The New England journal of medicine, Vol. 384, no.6, p. 497-511 (2021)
2020, ' Repurposed Antiviral Drugs for Covid-19-Interim WHO Solidarity Trial Results ', New England Journal of Medicine . https://doi.org/10.1056/NEJMoa2023184Test

مصطلحات موضوعية: Male, Kaplan Meier method, Intention to Treat Analysi, MESH: Treatment Failure, MESH: Hydroxychloroquine, remdesivir, Rate ratio, MESH: Intention to Treat Analysis, MESH: Length of Stay, law.invention, Lopinavir/*therapeutic use, 0302 clinical medicine, middle aged, Medicine, Hospital Mortality, MESH: Respiration, Artificial, Antiviral Agents/administration & dosage/adverse effects/*therapeutic use, comparative study, beta1a interferon, MESH: Middle Aged, Alanine, Respiration, adult, clinical trial, General Medicine, 3. Good health, Intention to Treat Analysis, [SDV] Life Sciences [q-bio], aged, health care quality, priority journal, drug withdrawal, Artificial, Interferon, Drug Therapy, Combination, medicine.medical_specialty, Initiation of ventilation, Interferon beta-1a/*therapeutic use, World Health Organization, Antiviral Agents, Article, Duration of hospital stay, antiviral drugs, 03 medical and health sciences, Drug Therapy, death, Humans, MESH: Hospital Mortality, human, MESH: Kaplan-Meier Estimate, Aged, MESH: Humans, treatment duration, extracorporeal oxygenation, Hydroxychloroquine, Length of Stay, major clinical study, mortality, Respiration, Artificial, Adenosine Monophosphate/*analogs & derivatives/therapeutic use, multicenter study, Alanine/*analogs & derivatives/therapeutic use, MESH: Interferon beta-1a, randomized controlled trial, MESH: Female, antivirus agent, [SDV]Life Sciences [q-bio], MESH: Hospitalization, Kaplan-Meier Estimate, 030204 cardiovascular system & hematology, Lopinavir, Adenosine Monophosphate, COVID-19, Female, Hospitalization, Interferon beta-1a, Middle Aged, Treatment Failure, Randomized controlled trial, Interquartile range, law, MESH: COVID-19, MESH: Adenosine Monophosphate, 030212 general & internal medicine, antiviral drugs, Covid-19, MESH: Aged, Hydroxychloroquine/*therapeutic use, MESH: Lopinavir, Covid19, artificial ventilation, drug therapy, ritonavir, hospital patient, female, Combination, medicine.drug, MESH: Antiviral Agents, combination drug therapy, COVID-19/*drug therapy/mortality, Randomization, MESH: Alanine, drug repositioning, drug clearance, adenosine phosphate, coronavirus disease 2019, length of stay, Internal medicine, controlled study, Antiviral Agent, Intention-to-treat analysis, business.industry, MESH: Male, COVID-19 Drug Treatment, purl.org/pe-repo/ocde/ford#3.02.00 [https], MESH: Drug Therapy, Combination, 3121 General medicine, internal medicine and other clinical medicine, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16340988d9937ca8ef93ad35262d9e60Test
https://hdl.handle.net/20.500.12866/9103Test

المؤلفون: Antonio Daniele Pinna, Natalie Filmann, Lionel Rostaing, Jens Brockmann, Michael Heise, Andreas A. Schnitzbauer, Simone I. Strasser, Giorgio Rossi, Silvio Nadalin, Jean Gugenheim, Tom M. Ganten, Umberto Cillo, Norman M. Kneteman, Koert P. de Jong, André Roy, Víctor Sánchez Turrión, Thomas Becker, Christoph Duvoux, Markus Rentsch, Jürgen Klempnauer, Utz Settmacher, George Philippe Pageaux, Christian Klein, Roberto Troisi, Edward K. Geissler, Darius F. Mirza, Gunnar Söderdahl, Peter Neuhaus, Jan Lerut, Hans J. Schlitt, Patrizia Burra, Vincenzo Mazzaferro, Johann Pratschke, T. Scholz, Neville V. Jamieson, Wolf O. Bechstein, James Powel, Thomas Soliman, Heikki Mäkisalo, Magnus Rizell, René Adam, Bart van Hoek, Michele Colledan, Itxarone Bilbao, Philippe Bachellier, Olivier Chazoullières, Sherrie Bhoori, Jaques Pirenne

المساهمون: UCL - SSS/IREC - Institut de recherche expérimentale et clinique, Schnitzbauer, A, Filmann, N, Adam, R, Bachellier, P, Bechstein, W, Becker, T, Bhoori, S, Bilbao, I, Brockmann, J, Burra, P, Chazoullieres, O, Cillo, U, Colledan, M, Duvoux, C, Ganten, T, Gugenheim, J, Heise, M, van Hoek, B, Jamieson, N, de Jong, K, Klein, C, Klempnauer, J, Kneteman, N, Lerut, J, Makisalo, H, Mazzaferro, V, Mirza, D, Nadalin, S, Neuhaus, P, Pageaux, G, Pinna, A, Pirenne, J, Pratschke, J, Powel, J, Rentsch, M, Rizell, M, Rossi, G, Rostaing, L, Roy, A, Scholz, T, Settmacher, U, Soliman, T, Strasser, S, Soderdahl, G, Troisi, R, Turrion, V, Schlitt, H, Geissler, E, Universitätsklinikum Frankfurt, Centre Hépato-Biliaire [Hôpital Paul Brousse] (CHB), Hôpital Paul Brousse-Assistance Publique - Hôpitaux de Paris, Les Hôpitaux Universitaires de Strasbourg (HUS), University Medical Center of Schleswig–Holstein = Universitätsklinikum Schleswig-Holstein (UKSH), Kiel University, IRCCS Istituto Nazionale dei Tumori [Milano], Vall d'Hebron University Hospital [Barcelona], Universitätsklinikum Münster, Universita degli Studi di Padova, CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Azienda Ospedaliera di Padova, Azienda Ospedaliera Ospedale Papa Giovanni XXIII [Bergamo, Italy], Hôpital Henri Mondor, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Henri Mondor-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), UniversitätsKlinikum Heidelberg, Centre Hospitalier Universitaire de Nice (CHU Nice), Leiden University Medical Center (LUMC), Cambridge University Hospitals - NHS (CUH), University of Cambridge [UK] (CAM), Addenbrooke's Hospital, Cambridge University NHS Trust, University Medical Center Groningen [Groningen] (UMCG), University of Groningen [Groningen], Universitätsklinikum Essen [Universität Duisburg-Essen] (Uniklinik Essen), Medizinische Hochschule Hannover (MHH), University of Alberta, Université Catholique de Louvain = Catholic University of Louvain (UCL), Helsinki University Hospital, University Hospitals Birmingham [Birmingham, Royaume-Uni], Queens Elizabeth Hospital [Birmingham], Universitätsklinikum Tübingen - University Hospital of Tübingen, Eberhard Karls Universität Tübingen = Eberhard Karls University of Tuebingen, Charité - UniversitätsMedizin = Charité - University Hospital [Berlin], Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Cellules Souches, Plasticité Cellulaire, Médecine Régénératrice et Immunothérapies (IRMB), Université de Montpellier (UM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Policlinico S. Orsola-malpighi, Alma Mater Studiorum Università di Bologna [Bologna] (UNIBO)-Servizio sanitario regionale Emilia-Romagna, UZLeuven, Royal Infirmary of Edinburgh, Ludwig-Maximilians-Universität München (LMU), Sahlgrenska University Hospital [Gothenburg], Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, CHU Grenoble, Centre Hospitalier de l'Université de Montréal (CHUM), Université de Montréal (UdeM), Uppsala University Hospital, Universitätsklinikum Jena [Jena], Medizinische Universität Wien = Medical University of Vienna, Royal Prince Alfred Hospital, Karolinska University Hospital [Stockholm], Ghent University Hospital, Hospital Universitario Puerta de Hierro-Majadahonda [Madrid, Spain], University Hospital Regensburg, Fraunhofer Institute for Toxicology and Experimental Medicine (Fraunhofer ITEM), Fraunhofer (Fraunhofer-Gesellschaft), Publica, Schnitzbauer, A. A., Filmann, N., Adam, R., Bachellier, P., Bechstein, W. O., Becker, T., Bhoori, S., Bilbao, I., Brockmann, J., Burra, P., Chazoullieres, O., Cillo, U., Colledan, M., Duvoux, C., Ganten, T. M., Gugenheim, J., Heise, M., van Hoek, B., Jamieson, N., de Jong, K. P., Klein, C. G., Klempnauer, J., Kneteman, N., Lerut, J., Makisalo, H., Mazzaferro, V., Mirza, D. F., Nadalin, S., Neuhaus, P., Pageaux, G. -P., Pinna, A. D., Pirenne, J., Pratschke, J., Powel, J., Rentsch, M., Rizell, M., Rossi, G., Rostaing, L., Roy, A., Scholz, T., Settmacher, U., Soliman, T., Strasser, S., Soderdahl, G., Troisi, R., Turrion, V. S., Schlitt, H. J., Geissler, E. K., Università degli Studi di Padova = University of Padua (Unipd), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Herrada, Anthony, Groningen Institute for Organ Transplantation (GIOT), Guided Treatment in Optimal Selected Cancer Patients (GUTS)

المصدر: Annals of Surgery, Vol. 272, no. 5, p. 855-862 (2020)
Annals of Surgery
Annals of Surgery, Lippincott, Williams & Wilkins, 2020, 272 (5), pp.855-862. ⟨10.1097/SLA.0000000000004280⟩
Annals of Surgery, 272(5), 855-862. LIPPINCOTT WILLIAMS & WILKINS
Annals of Surgery, 2020, 272 (5), pp.855-862. ⟨10.1097/SLA.0000000000004280⟩

مصطلحات موضوعية: Male, Oncology, [SDV.MHEP.CHI] Life Sciences [q-bio]/Human health and pathology/Surgery, medicine.medical_treatment, Medizin, Liver transplantation, MESH: Intention to Treat Analysis, mTOR-inhibition, 0302 clinical medicine, MESH: Liver Neoplasms, Clinical endpoint, MESH: Carcinoma, Hepatocellular, Milan criteria, MESH: Aged, MESH: Middle Aged, Liver Neoplasms, Hazard ratio, Middle Aged, Intention to Treat Analysis, 3. Good health, Survival Rate, 030220 oncology & carcinogenesis, Hepatocellular carcinoma, multivariate COX regression, Female, 030211 gastroenterology & hepatology, MESH: Immunosuppressive Agents, MESH: Neoplasm Recurrence, Local, Immunosuppressive Agents, medicine.drug, medicine.medical_specialty, MESH: Liver Transplantation, Carcinoma, Hepatocellular, MESH: Survival Rate, AFP, [SDV.MHEP.CHI]Life Sciences [q-bio]/Human health and pathology/Surgery, 03 medical and health sciences, Internal medicine, medicine, Carcinoma, Humans, Survival rate, Aged, Sirolimus, MESH: Humans, business.industry, medicine.disease, digestive system diseases, MESH: Male, Liver Transplantation, Surgery, MESH: Sirolimus, Neoplasm Recurrence, Local, business, MESH: Female

وصف الملف: application/pdf; Print

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1366a5a25685c35d3e6bad9d9a449956Test
https://hdl.handle.net/2078.1/235479Test

المؤلفون: Diane Ullman, Aicha Boukthir, Nabil Belhadj Hamida, Ryan C. Adams, Kirsten S. Smith, Mourad Mokni, Jihene Bettaieb, Zaher El Ahmadi, Philip L. Smith, Adel Gharbi, Robert M. Rice, George D. Thorne, Nissaf Ben Alaya, A. Zaatour, Carl J. Nielsen, Jeanne A. Norwood, Max Grogl, Hechmi Louzir, Sadok Chlif, Gloria Morizot, William F. McCarthy, Alan J. Magill, Afif Ben Salah, Mara Kreishman-Deitrick, Karen M. Kopydlowski, Janet Ransom, Judith Berman, Pierre Buffet, Nathalie Ben Messaoud, Kidar Abdelhamid, Evelyn Guedri, Douglas B. Tang

المساهمون: Institut Pasteur de Tunis, Réseau International des Instituts Pasteur (RIIP), Regional Hospital of Gafsa, Regional Directorate of Health, Department of Dermatology, Hôpital La Rabta [Tunis], Institut Pasteur [Paris], Immunité et Infection, Université Pierre et Marie Curie - Paris 6 (UPMC)-IFR113-Institut National de la Santé et de la Recherche Médicale (INSERM), U.S. Army Medical Materiel Development Activity, Fort Detrick, Fast-Track Drugs and Biologics, North Potomac, Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Supported by the Department of the Army. The investigators have adhered to the policies for protection of human subjects asprescribed in Army Regulation 70-25., Institut Pasteur [Paris] (IP)

المصدر: New England Journal of Medicine
New England Journal of Medicine, Massachusetts Medical Society, 2013, 368 (6), pp.524-32. ⟨10.1056/NEJMoa1202657⟩
New England Journal of Medicine, 2013, 368 (6), pp.524-32. ⟨10.1056/NEJMoa1202657⟩

مصطلحات موضوعية: Male, MESH: Paromomycin, Paromomycin, Administration, Topical, MESH: Intention to Treat Analysis, Ointments, 0302 clinical medicine, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, MESH: Child, MESH: Ointments, Medicine, Leishmania major, Child, MESH: Aged, 0303 health sciences, MESH: Middle Aged, Index Lesion, biology, General Medicine, Middle Aged, Intention to Treat Analysis, 3. Good health, MESH: Administration, Topical, MESH: Young Adult, Child, Preschool, Drug Therapy, Combination, Female, Gentamicin, medicine.symptom, medicine.drug, Adult, medicine.medical_specialty, MESH: Gentamicins, Adolescent, 030231 tropical medicine, Leishmaniasis, Cutaneous, Lesion, Young Adult, 03 medical and health sciences, Cutaneous leishmaniasis, parasitic diseases, Humans, Aged, 030304 developmental biology, MESH: Adolescent, Intention-to-treat analysis, MESH: Humans, business.industry, MESH: Child, Preschool, Leishmaniasis, MESH: Adult, medicine.disease, biology.organism_classification, MESH: Leishmaniasis, Cutaneous, Dermatology, MESH: Male, carbohydrates (lipids), MESH: Drug Therapy, Combination, Gentamicins, business, MESH: Female

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7048bbfb40ab6d667daf8f05bd432e4Test
https://hal-riip.archives-ouvertes.fr/pasteur-00793585/file/Topical_Paromomycin_with_or_without_Gentamicin_for_Cutaneous_Leishmaniasis.pdfTest

المؤلفون: Schulman, S1, Kearon, C, Kakkar, AK, Schellong, S, Eriksson, H, Baanstra, D, Kvamme, AM, Friedman, J, Mismetti, P, Goldhaber, SZ, Schulman, S, Goldhaber, S, Kakkar A, DI MINNO, GIOVANNI

المساهمون: Schulman, S, Kearon ,C, Kakkar ,AK, Schellong, S, Eriksson, H, Baanstra ,D, Kvamme, AM, Friedman ,J, Mismetti, P, Goldhaber, SZ, Siragusa, S, Cardiology, ACS - Amsterdam Cardiovascular Sciences, Vascular Medicine, Other departments, Schulman, S1, Kearon, C, Kakkar, Ak, Baanstra, D, Kvamme, Am, Friedman, J, Goldhaber, Sz, Goldhaber, S, Kakkar, A, DI MINNO, Giovanni, Department of Medicine (DM - McMaster), McMaster University [Hamilton, Ontario], Thrombosis Research Institute (AKK), University College of London [London] (UCL), Dresden-Friedrichstadt Hospital (DRESDEN-FRIEDRICHSTADT HOSPITAL), Dresden-Friedrichstadt Hospital, Centre d'Investigation Clinique - Epidemiologie Clinique/essais Cliniques Saint Etienne, Université Jean Monnet [Saint-Étienne] (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM), Groupe de recherche sur la thrombose (GRT (EA 3065)), Université Jean Monnet [Saint-Étienne] (UJM), Cardiovascular Division (SZG), Brigham and Women's Hospital [Boston], Centre d'Investigation Clinique (CIC - Brest), Université de Brest (UBO)-Institut National de la Santé et de la Recherche Médicale (INSERM), Groupe d'Etude de la Thrombose de Bretagne Occidentale (GETBO), Université de Brest (UBO)-Institut Brestois Santé Agro Matière (IBSAM), Université de Brest (UBO)-Université de Brest (UBO), Rheumatology, ICaR - Circulation and metabolism

المصدر: New England journal of medicine, 368(8), 709-718. Massachussetts Medical Society
New England Journal of Medicine
New England Journal of Medicine, Massachusetts Medical Society, 2013, 368 (8), pp.709-18. ⟨10.1056/NEJMoa1113697⟩
Schulman, S, Kearon, C, Kakkar, A K, Schellong, S, Eriksson, H, Baanstra, D, Kvamme, A M, Friedman, J, Nurmohamed, M T, Mismetti, P & Goldhaber, S Z 2013, ' Extended use of dabigatran, warfarin, or placebo in venous thromboembolism. ', New England Journal of Medicine, vol. 368, no. 8, pp. 709-718 . https://doi.org/10.1056/NEJMoa1113697Test
New England Journal of Medicine, 368(8), 709-718. Massachussetts Medical Society
Schulman, S, Kearon, C, Kakkar, A K, Schellong, S, Eriksson, H, Baanstra, D, Kvamme, A M, Friedman, J, Mismetti, P, Goldhaber, S Z & RE-MEDY Trial Investigators 2013, ' Extended use of dabigatran, warfarin, or placebo in venous thromboembolism ', The New England Journal of Medicine, vol. 368, no. 8, pp. 709-18 . https://doi.org/10.1056/NEJMoa1113697Test

مصطلحات موضوعية: Male, [SDV]Life Sciences [q-bio], 030204 cardiovascular system & hematology, MESH: Intention to Treat Analysis, MESH: Venous Thromboembolism, 0302 clinical medicine, MESH: Aged, 80 and over, Recurrence, 030212 general & internal medicine, MESH: Warfarin, Aged, 80 and over, MESH: Aged, MESH: Middle Aged, MESH: Risk, Hazard ratio, Atrial fibrillation, Venous Thromboembolism, General Medicine, MESH: Follow-Up Studies, Middle Aged, Intention to Treat Analysis, 3. Good health, Pulmonary embolism, MESH: International Normalized Ratio, MESH: beta-Alanine, MESH: Young Adult, Anesthesia, Female, MESH: Hemorrhage, medicine.drug, Adult, Risk, Adolescent, Hemorrhage, Lower risk, Placebo, Dabigatran, Dabigatran, Venous Thromboembolism, Young Adult, 03 medical and health sciences, medicine, Humans, International Normalized Ratio, Aged, MESH: Adolescent, Intention-to-treat analysis, MESH: Humans, business.industry, Warfarin, MESH: Adult, medicine.disease, MESH: Male, MESH: Recurrence, beta-Alanine, Benzimidazoles, business, MESH: Benzimidazoles, Venous thromboembolism, MESH: Female, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49c6d84e6bef3f708aafee8a518c7246Test
http://hdl.handle.net/10447/96631Test

المؤلفون: David Clayton, Robert Cuddihy, Jose Antônio Marin-Neto, Jeanne Clark, Esra Hatipoglu, Mohd Shazli Draman, Alfredo Ramirez, Philip Böhme, Victor Gurevich, Miguel Urina, Angel L. Fernández, Maja Cigrovski Berkovic, Valdis Pirags, Evgeny Shkolnik, Alexander Vonbank, Salim Yusuf, Heather Lochnan, Jan Cornel, Bu Yeap, Tatiana Adasheva, Giuseppe Derosa, Aldo Pietro Maggioni, ALVARO AVEZUM, Igor Bondarenko, Monica Acevedo, Francesco Cacciatore, A.S. Ametov, Weiping Jia, Iana Orlova, Anders Waldenström, B. L. Gregoire Nyomba, Neslihan Bascil Tutuncu, Tristan Richardson, Anastasia F Hutchinson, Vladimir Zadionchenko, Sudeep K, Moti Kashyap, Adrian Vlad, Aivars Lejnieks, Jeong-Taek Woo, Fernando Lanas, Nicolae Hancu, Kurt Boman, Cristina Facanha, Laura Bryan, Louise Bordeleau, Patricio Lopez-Jaramillo, Adriana Forti, Flavia Lucia Lombardo, Gunnar Gislason, Malgorzata Sikora-Frac, Peter Colman, Veronique Kerlan, Olga Bulkina, Melanie Davies, Maira Marino, JAIME CARMONA-HUERTA, Hertzel Gerstein, Jackie Bosch, Carlos Morillo, Alina Babenko, Philip Aylward, SONIA GAZTAMBIDE, Yury Vasyuk, Asem Ali, Ragnar Martin Joakimsen, Anna Novials, Andrzej Budaj, Anne Taylor

المساهمون: Department of General Surgery. Surgical Oncology Unit, Reina Sofía University Hospital, Population Health Research Institute, Groupe d'Etude de la Thrombose de Bretagne Occidentale (GETBO), Université de Brest (UBO)-Institut Brestois Santé Agro Matière (IBSAM), Université de Brest (UBO)-Université de Brest (UBO), Service d'Endocrinologie (CHRU - Endocrino), Centre Hospitalier Régional Universitaire de Brest (CHRU Brest)

المصدر: New England Journal of Medicine
New England Journal of Medicine, Massachusetts Medical Society, 2012, 367 (4), pp.309-18. ⟨10.1056/NEJMoa1203859⟩
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP

مصطلحات موضوعية: Male, MESH: Treatment Failure, medicine.medical_treatment, [SDV]Life Sciences [q-bio], Insulin Glargine, 030204 cardiovascular system & hematology, MESH: Intention to Treat Analysis, MESH: Proportional Hazards Models, chemistry.chemical_compound, 0302 clinical medicine, MESH: Cholesterol, dysglycemia, MESH: Fatty Acids, Omega-3, MESH: Double-Blind Method, Treatment Failure, 030212 general & internal medicine, MESH: Incidence, MESH: Aged, MESH: Middle Aged, Dysglycemia, cardiovascular events, Incidence, General Medicine, MESH: Follow-Up Studies, Middle Aged, INFARTO DO MIOCÁRDIO, Intention to Treat Analysis, 3. Good health, Insulin, Long-Acting, Cholesterol, Cardiovascular Diseases, n-3 fatty acid, Cardiology, Drug Therapy, Combination, Female, medicine.drug, MESH: Diabetes Mellitus, Type 2, MESH: Triglycerides, medicine.medical_specialty, MACE diabetes glargin, 03 medical and health sciences, Pharmacotherapy, Double-Blind Method, Internal medicine, Diabetes mellitus, MESH: Hypoglycemic Agents, Fatty Acids, Omega-3, Glucose Intolerance, medicine, Humans, Hypoglycemic Agents, Triglycerides, MESH: Glucose Intolerance, Aged, Proportional Hazards Models, Intention-to-treat analysis, MESH: Humans, business.industry, Insulin glargine, Proportional hazards model, Insulin, MESH: Cardiovascular Diseases, medicine.disease, MESH: Male, MESH: Drug Therapy, Combination, Endocrinology, Diabetes Mellitus, Type 2, chemistry, Heart failure, MESH: Insulin, Long-Acting, business, MESH: Female, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f39e22cbebb9e550f06d72fbe46c60e9Test
https://hal.univ-brest.fr/hal-00931578Test

المؤلفون: Büller, Hr, Gallus, As, Prins, Mh, Raskob, G, Decousus, H, Charbonnier, B, Leizorovicz, A, Laporte, S, Quenet, S, Brandjes, Dp, Middeldorp, S, Blüguermann, J, Amuchastegui, L, Ahuad Guerrero, R, Oberti, P, Alvarez, C, Cassettari, A, Santos, D, Macin, S, Santini, F, Ward, C, Coughlin, P, Salem, H, Gan, E, Leyden, M, Prosser, I, Crispin, P, Carroll, P, Gallus, A, Mcrae, S, Waites, J, Pilger, E, Koppensteiner, R, Kyrle, P, Schinko, H, Mrochek, A, Mitkovskaya, N, Prystrom, A, Motte, S, Ninane, V, Delcroix, M, Hainaut, P, Schneider, E, Saraiva, J, Maia, L, Barreto, S, Fernandes Manenti, E, Araujo, G, Dutra, O, Fiss, E, Moreira, R, Yankov, K, Nenkova, S, Ivanov, Y, Kostov, V, Bhargava, R, Chan, Y, Miron, Mj, Cusson, J, Ugarte, S, Morales, A, Andresen, M, Lanas, F, Arriagada, G, Mendoza, Jj, Zuñiga, C, Sepulveda, P, Wang, C, Liu, Z, Yuan, Y, Ma, Z, Fang, B, Liu, J, Bai, C, Wu, H, Yang, L, Ying, K, Kang, J, Li, Q, Cheng, Z, Zhang, J, Wang, H, Xie, C, Xia, G, Du, Y, Wu, Q, Zhou, X, Chen, L, Yi, Q, Wu, C, Hao, Q, Liu, S, Xiong, S, Jiang, S, Zhao, L, Xiao, Q, Qin, Z, Zhou, J, Dennis, R, Miserque, N, Igueredo, M, Londoño, D, Hildebrando, J, Granados, M, Buitrago, R, Solano, Mh, Pacheco Alvis PM, Botero, R, Saenz, O, Bergovec, M, Padovan, M, Vucic, N, Samarzija, M, Chlumsky, J, Spacek, R, Klimsa, Z, Gregor, P, Povolny, J, Podpera, I, Holm, F, Lang, P, Matoska, P, Sabl, P, Spinar, J, Spac, J, Husted, S, Avnstrom, S, Rasmussen, S, Christensen, A, Guindy, R, Hassanein, M, Paumets, M, Meriste, S, Ferrari, E, Achkar, A, Azarian, R, Meneveau, N, Lorut, C, Mouallem, J, Crestani, B, Proton, A, Salmeron, S, Lerousseau, L, Mottier, D, Wahl, D, Siafakas, N, Papadimitriou, D, Katis, K, Katsaris, G, Gaga, A, Damianos, A, Tipparaju, S, Kalkunte, S, Vidhut, J, Kalashetti, S, Mehta, P, Talwar, D, Ramanathan, R, Mishra, R, Zeltzer, D, Lahav, M, Brenner, B, Caraco, Y, Elias, M, Piovella, F, Barone, M, Poggio, R, Palla, A, Ghirarduzzi, A, Pini, M, Lodigiani, C, Prandoni, Paolo, Agnelli, G, Imberti, D, Scannapieco, G, Salvi, A, Bautista, E, Diaz, J, Mercado, R, Ranero, A, Rodriguez, D, Jerjes, C, Villeda Espinoza, E, Van Der Meer, J, Ijfering, W, Van Marwijk Kooy, M, Boersma, W, Van Leendert, R, Kroon, C, Dullemond Westland, A, Viergever, P, Kuipers, A, Grootenboers, M, Creemers, J, Pieters, W, De Munck, D, Timmer, H, Jackson, S, Sandset, P, Meyer, P, Kristiansen, T, Portugal, J, Paz, E, Salazar, D, Chavez, W, Castillo, L, De Guia, T, Lenora, F, Tomkowski, W, Kloczko, J, Rybak, Z, Gaciong, Z, Sobkowicz, B, Pruszczyk, P, Nizankowski, R, Mirek Bryniarska, E, Kukla, P, Reis, A, França, A, Cortez, M, Sa, J, Santos, F, Marques, Ma, Gordeev, I, Gendlin, G, Yablonsky, P, Sokurenko, G, Soroka, V, Lusov, V, Markov, V, Shvats, Y, Katerlnitskiy, I, Lapin, O, Lyamina, N, Subbotin, Y, Kim, I, Zilber, E, Kchaisheva, L, Poliacik, P, Macek, V, Pretorius, Jp, Abdullah, I, Basson, M, Bollinger, C, Breedt, J, Gani, M, Jansen, J, Le Roux, G, Nortje, H, Van Der Linder, M, Van Zyl, L, Viljoen, J, Bruning, A, Pujol Farriols, R, Raguer, E, Nuffal, D, Sanchez Rodriguez, A, Eriksson, H, Almgren, T, Carlsson, A, Elf, J, Olsson, Cg, Aagesen, J, Savas, I, Sahin, A, Erdogan, Y, Ozhan, M, Ongen, G, Celikel, T, Turker, H, Arseven, O, Tuncay, E, Ozacar, R, Gudz, I, Nykonenko, O, Skupyy, O, Kovalskyy, I, Prasol, V, Cohen, A, Rodriguez Cintron, W, Gurka, D, Bradley, J, Oliver, G, Spyropoulos, A, Lerner, R, Fulmer, J, Lu, Np, Wright, P, Han, D, Servi, R, Nadar, V, Quaranta, A, Gehring, J, Ginsberg, R, Jacobson, A, Colan, D, Vanway, C, Gurza, E, Braslow, B, Shorr, A, Rehm, J, Martin, J, Sellers, M, Concha, M, Gordon, I, Pullman, J, Moran, J, Welker, J, Panzarella, P, Mullins, M, Willms, D, Mcgrew, F, Turki, M, Menajovsky, L.

المساهمون: Epidemiologie, MUMC+: KIO Kemta (9), RS: CAPHRI School for Public Health and Primary Care, Amsterdam Cardiovascular Sciences, Vascular Medicine, Department of Vascular Medicine (DVM - AMC), Academic Medical Center - Academisch Medisch Centrum [Amsterdam] (AMC), University of Amsterdam [Amsterdam] (UvA)-University of Amsterdam [Amsterdam] (UvA), SA Pathology at Flinders Medical Center (ASG), Flinders University, Department of Epidemiology (MHP), Maastricht University [Maastricht], College of Public Health (CPH), University of Oklahoma (OU), Centre d'Investigation Clinique (CIC - Brest), Université de Brest (UBO)-Institut National de la Santé et de la Recherche Médicale (INSERM), Groupe d'Etude de la Thrombose de Bretagne Occidentale (GETBO), Université de Brest (UBO)-Institut Brestois Santé Agro Matière (IBSAM), Université de Brest (UBO)-Université de Brest (UBO)

المصدر: Lancet, 379(9811), 123-129. Elsevier Science
Lancet, 379(9811), 123-129. Elsevier Limited
Lancet
Lancet, Elsevier, 2012, 379 (9811), pp.123-9. ⟨10.1016/S0140-6736(11)61505-5⟩

مصطلحات موضوعية: Male, MESH: Pulmonary Embolism, Oligosaccharides, MESH: Factor X, 030204 cardiovascular system & hematology, MESH: Intention to Treat Analysis, MESH: Aged, 80 and over, 0302 clinical medicine, MESH: Double-Blind Method, 030212 general & internal medicine, MESH: Warfarin, Aged, 80 and over, MESH: Aged, education.field_of_study, Idrabiotaparinux, MESH: Middle Aged, General Medicine, Heparin, Middle Aged, Intention to Treat Analysis, 3. Good health, Pulmonary embolism, Acute Disease, MESH: Acute Disease, Drug Therapy, Combination, Female, medicine.drug, Adult, medicine.medical_specialty, MESH: Enoxaparin, Adolescent, Population, Biotin, MESH: Anticoagulants, Double blind, 03 medical and health sciences, Double-Blind Method, Internal medicine, MESH: Biotin, medicine, Humans, Enoxaparin, education, Aged, MESH: Adolescent, MESH: Humans, Intention-to-treat analysis, business.industry, Warfarin, Anticoagulants, MESH: Adult, Odds ratio, medicine.disease, MESH: Male, Surgery, MESH: Drug Therapy, Combination, Factor X, Pulmonary Embolism, business, MESH: Female, MESH: Oligosaccharides, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2cef81233461dd5dcb497955b4d24c6Test
https://cris.maastrichtuniversity.nl/en/publications/70fa0a5d-d76f-4e74-9002-0f44cf51ae9fTest

المؤلفون: David Clayton, Robert Cuddihy, Jose Antônio Marin-Neto, Esra Hatipoglu, Mohd Shazli Draman, Alfredo Ramirez, Philip Böhme, Victor Gurevich, Miguel Urina, Angel L. Fernández, Maja Cigrovski Berkovic, Valdis Pirags, Evgeny Shkolnik, Alexander Vonbank, Salim Yusuf, Heather Lochnan, Jan Cornel, Bu Yeap, Tatiana Adasheva, Giuseppe Derosa, Aldo Pietro Maggioni, ALVARO AVEZUM, Igor Bondarenko, Monica Acevedo, Francesco Cacciatore, A.S. Ametov, Weiping Jia, Anders Waldenström, B. L. Gregoire Nyomba, Neslihan Bascil Tutuncu, Tristan Richardson, Anastasia F Hutchinson, Vladimir Zadionchenko, Sudeep K, Moti Kashyap, Adrian Vlad, Aivars Lejnieks, Jeong-Taek Woo, Fernando Lanas, Nicolae Hancu, Kurt Boman, Cristina Facanha, Laura Bryan, Louise Bordeleau, Patricio Lopez-Jaramillo, Adriana Forti, Flavia Lucia Lombardo, Gunnar Gislason, Malgorzata Sikora-Frac, Peter Colman, Veronique Kerlan, Olga Bulkina, Melanie Davies, JAIME CARMONA-HUERTA, Hertzel Gerstein, Jackie Bosch, Carlos Morillo, Alina Babenko, Philip Aylward, SONIA GAZTAMBIDE, Yury Vasyuk, Asem Ali, Ragnar Martin Joakimsen, Anna Novials, Andrzej Budaj, Anne Taylor

المساهمون: Department of Medicine (DM - McMaster), McMaster University [Hamilton, Ontario], Population Health Research Institute, Institut Universitaire de Cardiologie (QUEBEC - IUCP), Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ), Université Laval [Québec] (ULaval)-Université Laval [Québec] (ULaval), Department of General Surgery. Surgical Oncology Unit, Reina Sofía University Hospital, Groupe d'Etude de la Thrombose de Bretagne Occidentale (GETBO), Université de Brest (UBO)-Institut Brestois Santé Agro Matière (IBSAM), Université de Brest (UBO)-Université de Brest (UBO), Service d'Endocrinologie (CHRU - Endocrino), Centre Hospitalier Régional Universitaire de Brest (CHRU Brest)

المصدر: New England Journal of Medicine
New England Journal of Medicine, Massachusetts Medical Society, 2012, 367 (4), pp.319-28. ⟨10.1056/NEJMoa1203858⟩
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP

مصطلحات موضوعية: Blood Glucose, Male, MESH: Hypoglycemia, medicine.medical_treatment, [SDV]Life Sciences [q-bio], Insulin Glargine, Type 2 diabetes, MESH: Hospitalization, 030204 cardiovascular system & hematology, MESH: Intention to Treat Analysis, Impaired glucose tolerance, MESH: Proportional Hazards Models, 0302 clinical medicine, MESH: Cholesterol, MESH: Fatty Acids, Omega-3, dysglycemia, MESH: Double-Blind Method, Basal insulin, MESH: Incidence, MESH: Aged, MESH: Middle Aged, Incidence, Hazard ratio, Fasting, General Medicine, MESH: Follow-Up Studies, Middle Aged, Intention to Treat Analysis, 3. Good health, Hospitalization, Insulin, Long-Acting, Cholesterol, Cardiovascular Diseases, Drug Therapy, Combination, Female, medicine.drug, MESH: Diabetes Mellitus, Type 2, MESH: Triglycerides, medicine.medical_specialty, MACE diabetes glargin, MESH: Fasting, HIPOGLICEMIA, 030209 endocrinology & metabolism, Hypoglycemia, 03 medical and health sciences, Double-Blind Method, Diabetes mellitus, Internal medicine, MESH: Hypoglycemic Agents, Fatty Acids, Omega-3, Glucose Intolerance, medicine, Humans, Hypoglycemic Agents, Triglycerides, MESH: Glucose Intolerance, Aged, Proportional Hazards Models, MESH: Humans, business.industry, Insulin glargine, Insulin, MESH: Cardiovascular Diseases, medicine.disease, Impaired fasting glucose, MESH: Male, basal insulin, MESH: Drug Therapy, Combination, Endocrinology, Diabetes Mellitus, Type 2, MESH: Blood Glucose, MESH: Insulin, Long-Acting, business, MESH: Female, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::634f88b8e1e558a67f133168a51ce3b3Test
http://hdl.handle.net/11577/2533486Test

المؤلفون: Karim Boudjema, Bernard Meunier, Christophe Camus, Vianney Bouygues, M. Lakehal, Philippe Compagnon, Edouard Bardou-Jacquet, Marianne Latournerie

المساهمون: Le Corre, Morgane, Service de Chirurgie Hépatobiliaire et Digestive [Rennes] = Hepatobiliary and Digestive Surgery [Rennes], CHU Pontchaillou [Rennes], Service des maladies du foie [CHU Rennes], Centre Hospitalier Universitaire [Rennes], Service des maladies infectieuses et réanimation médicale [Rennes] = Infectious Disease and Intensive Care [Rennes], Service des maladies du foie, Centre Hospitalier Universitaire [Rennes]-Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Hôpital Pontchaillou

المصدر: Clinics and Research in Hepatology and Gastroenterology
Clinics and Research in Hepatology and Gastroenterology, Elsevier, 2012, 36 (5), pp.464-72. ⟨10.1016/j.clinre.2012.07.009⟩

مصطلحات موضوعية: Male, medicine.medical_specialty, MESH: Liver Transplantation, medicine.medical_treatment, 030230 surgery, Liver transplantation, Single Center, MESH: Intention to Treat Analysis, 03 medical and health sciences, 0302 clinical medicine, medicine, Humans, MESH: Patient Selection, 10. No inequality, MESH: Models, Theoretical, Survival rate, Retrospective Studies, Intention-to-treat analysis, MESH: Humans, MESH: Middle Aged, Hepatology, business.industry, Incidence (epidemiology), Patient Selection, Disease progression, Gastroenterology, Retrospective cohort study, MESH: Retrospective Studies, [SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology, Middle Aged, Models, Theoretical, [SDV.MHEP.HEG] Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology, MESH: Male, 3. Good health, Surgery, Intention to Treat Analysis, Liver Transplantation, Transplantation, body regions, 030211 gastroenterology & hepatology, Female, business, MESH: Female

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1667a78c1e74dd0d1d922d3268ba392Test
https://www.hal.inserm.fr/inserm-00865342Test

المؤلفون: Keith Fox, Scott Berkowitz, Konstantin Ramshev, Jacek Kubica, Miguel Urina, Sotir Marchev, Graeme Hankey, WILLIAM HEDDLE, Claudio Marabotti, Michel GALINIER, Philippe Gabriel STEG, Vladimir Zadionchenko, Fernando Lanas, Juan Mauricio Pardo-Oviedo, Malcolm Robert Macleod, Dorairaj Prabhakaran, Vadim Mazurov, Larisa Yena, Aleksandr DEMIN

المساهمون: Mount Sinai Medical Center, Icahn School of Medicine at Mount Sinai [New York] (MSSM), Division of Cardiovascular Research (EDINBURGH - DCVR), University of Edinburgh, Diener, Hans Christoph (Beitragende*r)

المصدر: New England Journal of Medicine
New England Journal of Medicine, Massachusetts Medical Society, 2011, 365 (10), pp.883-91. ⟨10.1056/NEJMoa1009638⟩
The New England Journal of Medicine
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
ResearcherID
BASE-Bielefeld Academic Search Engine

مصطلحات موضوعية: Male, [SDV]Life Sciences [q-bio], Embolism, Medizin, Management of atrial fibrillation, Administration, Oral, Randomization, 030204 cardiovascular system & hematology, MESH: Intention to Treat Analysis, chemistry.chemical_compound, 0302 clinical medicine, MESH: Aged, 80 and over, Rivaroxaban, Edoxaban, Atrial Fibrillation, Medicine, MESH: Double-Blind Method, 030212 general & internal medicine, MESH: Warfarin, Stroke, MESH: Treatment Outcome, Aged, 80 and over, MESH: Aged, MESH: Middle Aged, Hazard ratio, Diabetes, General Medicine, Middle Aged, MESH: Thiophenes, 3. Good health, Intention to Treat Analysis, MESH: Atrial Fibrillation, Treatment Outcome, Anesthesia, Hypertension, MESH: Administration, Oral, Female, MESH: Hemorrhage, medicine.drug, Morpholines, MESH: Morpholines, Hemorrhage, Thiophenes, MESH: Anticoagulants, MESH: Stroke, Dabigatran, 03 medical and health sciences, Double-Blind Method, Humans, Aged, HAS-BLED, MESH: Humans, business.industry, Warfarin, Anticoagulants, medicine.disease, MESH: Male, chemistry, business, MESH: Female, MESH: Embolism

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a251ed4738fc9d57f063feef4b22b7bfTest
https://hal.univ-brest.fr/hal-01038111Test